ESR1 and breast carcinoma: In our cohort of breast cancer cases and in five breast cancer cell lines, as well as in an independent in silico data set of 283 breast cancer retrieved from TCGA [22], we confirmed the strong positive association between miR-342 expression and ER status, as miR-342 was more highly expressed in ER-positive than in ER-negative cases and cell lines.